ArticleJournal of the Association for Research in Otolaryngology : JARO2024

FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.

Zhiwei Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.